| Identifier | Protein names | Gene names | Cross reference refseq | Length | Species |
| A0A024RAF9 | Heparan sulfate 6-O-sulfotransferase 1, isoform CRA_a; | HS6ST1; | NULL | 411 | human |
| Q15HG3 | Cytochrome c oxidase subunit 3; | COX3; | NULL | 261 | human |
| E9PNY0 | A/G-specific adenine DNA glycosylase; | MUTYH; | NULL | 216 | human |
| A0A024R0B8 | Uncharacterized protein; | FLJ21657; | NULL | 215 | human |
| Q7RTW4 | Neuregulin 1 isoform HRG-beta1; Neuregulin 1, isoform CRA_i; | NRG1; | NULL | 645 | human |
| D3DWU2 | HCG2007944, isoform CRA_a; | NULL | NULL | 75 | human |
| Q2MD47 | B-cell linker protein; Fragment; | BASH; BLNK SLP65; | NULL | 121 | human |
| Q9H6K0 | CDNA: FLJ22202 fis, clone HRC01333; HCG1785839; | NULL | NULL | 170 | human |
| Q5SZR7 | Ornithine decarboxylase antizyme 3; | OAZ3; | NULL | 66 | human |
| F2Z2Z7 | Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial; | MCCC1; | NULL | 61 | human |
| A0A024R2F4 | THUMP domain containing 3, isoform CRA_a; | THUMPD3; | NULL | 507 | human |
| E7BWR8 | HCG2043595, isoform CRA_a; KIR2DL1; | KIR2DL1; | NULL | 348 | human |
| B5MC10 | Protein Mpv17; | MPV17; | NULL | 99 | human |
| B4E1B1 | Interferon regulatory factor 7, isoform CRA_c; cDNA FLJ61529, highly similar to Interferon regulatory factor 7; | IRF7; | NULL | 210 | human |
| A0A075B6K0 | HCG2041221; Protein IGLV3-16; Fragment; | IGLV3-16; | NULL | 112 | human |
| E9PJT1 | Phosphatidylinositol-binding clathrin assembly protein; | PICALM; | NULL | 48 | human |
| J3KQ52 | Granzyme B; Granzyme B (Granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1), isoform CRA_b; | GZMB; | NULL | 235 | human |
| A0A024RBL7 | MTERF domain containing 3, isoform CRA_a; | MTERFD3; | NULL | 385 | human |
| B4DMZ6 | Matrix metalloproteinase-23; cDNA FLJ60714, highly similar to Homo sapiens matrix metallopeptidase 23B (MMP23B), mRNA; | MMP23B; | NULL | 238 | human |
| B7Z6I5 | Peroxisomal biogenesis factor 19, isoform CRA_a; cDNA FLJ52066, highly similar to Peroxisomal biogenesis factor 19; | PEX19; | NULL | 209 | human |
UrgentMab™: Thinking is cheap. Test your ideas, fast and furious. |
 |
|
Custom monoclonal antibody in one month. As low as $200-300 per antigen. |
|
A product of Absolution |
|
SEAL™: Today's out-of-reach protein targets made accessible. |
|
|
Same budget, 5-10 times more antibodying SEAL your protein. Successes too. |
|
A product of Absolution |
|
PETAL™: Fast and high throughput antibody discover platform. |
 |
|
Deliver customized antibody in two weeks at price of category antibody Proteome-scale antibody discovery for any organism or proteome Biomarker discovery for biological processes or human diseases |
|
A product of Absolution |
|
AbFocus™: Target all the modification sites of your protein, affordably. |
|
|
Test them with a panel of AbFocus antibodies It is so affordable that you can focus on testing, not guessing |
|
A product of Absolution |
Mabome™: Catch the antibody gold rush.? Lead the next omics revolution. |
|
|
First-ever antibody proteomics technology. High quality monoclonal antibodies for your favorite proteome. As low as $19/monoclonal antibody |
|
A product of Absolution |
AbTarget™: Performing antibody for your proteome.? Guaranteed |
|
|
Fast, efficient monoclonal antibody development for proteins in a proteome Pay for successful antibodies only |
|
A product of Absolution |
AbProfile™: Discover an array of unbiased differences.? Proteome-scale |
|
|
50,000 monoclonal antibodies on an array.100 times more content. Differential profiling thousands of cell surface receptorsand plasma proteins |
|
A product of Absolution |
|
SMAL™:?All big things have a SMAL beginning. |
|
|
High success rate for mAb generation Deliver a panel of high affinity mAbs Flexible and optional fee structure for minimizing risks |
|
A product of Absolution |
AbX™: X=anything.? Find your antibody within |
|
|
currently 7species.?200,000 mAbs.70,000 proteins 3 new organisms are being AbXed/day Pre-made anti-peptide mAbs against all proteins in nature. |
|
A product of AbStore |
AbStop™: The last stop of antibody development. The most successful stop. |
|
|
Pre-designed antibody packages against high value targets The most aggressive and comprehensive protein targeting Best for diagnostics and therapeutic antibody development |
|
A product of AbStore |